RVL Pharmaceuticals Announces that Upneeq® Wins “Best Eye Drop for Drooping Lids” NewBeauty in 13th Annual Beauty Awards
Selected from 10,000 Entrants BRIDGEWATER, N.J., April 03, 2023 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc…
Year: 2023
Medigene enters Cooperative Research and Development Agreement with the National Cancer Institute to evaluate the use of Medigene’s proprietary T cell receptors in novel cell constructs
Martinsried/Munich, April 3, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology…
Mustang Bio Announces Reverse Stock Split
WORCESTER, Mass., April 03, 2023 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang” or the “Company”)…
Verizon brings the Small Business Digital Ready experience to live event in San Diego
BASKING RIDGE, N.J., April 03, 2023 (GLOBE NEWSWIRE) — Verizon announced it will host the…
Turnium Technology Group Creates Special Committee to Review Non-Binding LOI to Acquire the Shares of the Company
Vancouver, Canada–(Newsfile Corp. – April 3, 2023) – Turnium Technology Group Inc. (TSXV: TTGI) (“Turnium”…
H.I.G. Capital Completes the Sale of Buck
NEW YORK–(BUSINESS WIRE)–#Acquisition–H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $55 billion of…
Harris Williams Advises Ethos Capital on its Acquisition of Newforma
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it…
NetApp Appoints Haiyan Song Executive Vice President and General Manager of CloudOps Business
Cloud Industry Veteran to Lead Company’s Rapidly Growing, Highly Strategic Business Unit SAN JOSE, Calif.–(BUSINESS…
Publication of the Number of Shares Composing the Share Capital and of the Total Number of Voting Rights as of March 31, 2023
Nicox SA Société anonyme with a registered capital of € 50,156,698 Head Office: DRAKKAR D 2405 route…
Rookout Makes Snapshots the Fourth Pillar of Observability, Capturing Deep Code-Level Insights for Developers
Traditional observability telemetry consists of metrics, logs, and traces. Snapshots capture code-level, context-rich pictures of…
LevaData Introduces New Industry-Leading Capabilities for Spend Intelligence and Lead Time Visibility
The company’s most impactful platform release to date provides a major boost to companies looking…
nOps Announces New Innovations in Its Comprehensive Solution for Enterprises
San Francisco, California–(Newsfile Corp. – April 3, 2023) – nOps continues to revolutionize the AWS…
Coinweb has Closed $2 Million Fundraising Round from SAVA Investment Management
HONG KONG, Apr 3, 2023 – (ACN Newswire) – SAVA Investment Management, a licensed fund…
Cleverbridge Appoints Dr. Markus A. Wesel as Its Chief Financial Officer
Cologne, Germany, Apr 3, 2023 – (ACN Newswire) – Cleverbridge is pleased to appoint Dr….
Bid on a Private Lunch With Ray Dalio to Help Support Financial Education for All Students
Helping the Council for Economic Education Build Life Skills Nationwide NEW YORK–(BUSINESS WIRE)–#CEE—Ray Dalio, New…
Tricia Breeger Named CEO of Mitsubishi Electric Power Products, Inc.
WARRENDALE, Pa.–(BUSINESS WIRE)–Mitsubishi Electric Power Products, Inc., (MEPPI) today announced current President Tricia Breeger as…
april Launches AI-Driven Tax Solution, Disrupting Archaic Tax System to Usher in a Consumer-Friendly Future
In partnership with Acorns, Mercury Financial, B9, Moves, and others april is embedding AI-powered tax…
Morgan Stanley Capital Partners Enters Agreement to Sell Ovation Fertility to US Fertility
NEW YORK–(BUSINESS WIRE)–Investment funds managed by Morgan Stanley Capital Partners (“MSCP”), the middle-market focused private…
INmune Bio, Inc. Announces Submission of Investigational New Drug (IND) Application for INKmune™ to the U.S. Food and Drug Administration for Treatment of Metastatic Castration-Resistant Prostate Cancer
BOCA RATON, Fla., April 03, 2023 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a…
INmune Bio, Inc. Announces Submission of Investigational New Drug (IND) Application for INKmune™ to the U.S. Food and Drug Administration for Treatment of Metastatic Castration-Resistant Prostate Cancer
BOCA RATON, Fla., April 03, 2023 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a…